PET (positron emission tomography) for cancer in US: CMS amends decision
This article was originally published in Clinica
Executive Summary
The US Centers for Medicare & Medicaid Services (CMS) has modified its earlier coverage proposal regarding cancer applications for positron emission tomography (PET) to allow scans for testicular cancer in certain cases.